Coverage
-
December 10, 2013
Genetic testing company Invitae Corp. asked a Utah federal court Monday to throw out Myriad Genetics Inc.'s suit alleging Invitae infringed on its patents relating to genetic screening for breast cancer, saying the court lacks jurisdiction because Invitae has no contacts in Utah.
1 other articles on this case.
View all »